AzTrials
AzTrials

AgedNCT06901167

Evaluation of a Residential In-Reach Program in Regional and Rural Australia

A study testing Residential In-Reach Program in people with Aged and Acute Disease, run by Monash University at 8 sites in Australia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Residential In-Reach (RIR) programs are designed to provide responsive care for residents in residential aged care homes (RACH) with the aim of avoiding unnecessary hospital transfers. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Aged, Acute Disease
What is being tested?
Residential In-Reach Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
8 sitesAustralia
Study dates
1 May 2025to 30 Jun 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Health services that have emergency departments and/or emergency care centres that admit residents from residential aged care homes (RACH)
  • RACHs that do not currently have access to RIR programs
  • health service staff who have been involved with the set-up and delivery of the RIR program,
  • RACH staff who have experience of or accessing the RIR service for residents at least once,
  • residents living at a RACH who has experienced receiving medical care from the RIR program and can provide informed consent, or a family member of the resident,
  • general practitioners whose case load includes residents from RACHs.

Who cannot join

  • RACHs that already have access to a RIR program will be excluded

Trial locations and contacts

8 sites in 1 country. Contact the study team or a site near you to ask about taking part.

8 sites in 1 country

Australia8 sites, 8 recruiting
  • East Grampians Health Service

    Ararat, Victoria, 3377

    Michele Colin, 61 03 5352 9300, michele.conlin@eghs.net.au

    Michele Conlin

    Recruiting
  • Grampians Health

    Ballarat, Victoria, 3350

    Narelle Ryan, 61 0417 590 832, narelle.Ryan@gh.org.au

    Narelle Ryan

    Recruiting
  • Beaufort and Skipton Health Service

    Beaufort, Victoria, 3373

    Andrea Flenley, 61 03 5349 1600, andreaf@bshs.org.au

    Recruiting
  • Central Highlands Rural Health

    Daylesford, Victoria, 3460

    Susan Jennings, 61 03 5321 6500, susan.jennings@chrh.org.au

    Recruiting
  • Maryborough District Health Service

    Maryborough, Victoria, 3465

    Debbie Rogers, 61 03 5461 0333, drogers@mdhs.vic.gov.au

    Recruiting
  • West Wimmera Health Service

    Nhill, Victoria, 3418

    Cheree Schneider, 61 03 5391 4222, Cheree.Schneider@wwhs.net.au

    Recruiting
  • East Wimmera Health Service

    Saint Arnaud, Victoria, 3478

    Genette Heslop, 61 03 5477 2100, genette.heslop@ewhs.org.au

    Recruiting
  • Rural Northwest Health

    Warracknabeal, Victoria, 3393

    Joseph Bermudo, 61 03 5396 1200, josph.bermudo@rnh.net.au

    Recruiting

Other trials in Australia

About this study

Official title: Evaluation of a Region-wide Residential In-Reach (RIR) Program in Regional and Rural Health Services: A Stepped-wedge Trial

Residential In-Reach (RIR) programs are designed to provide responsive care for residents in residential aged care homes (RACH) with the aim of avoiding unnecessary hospital transfers. The evidence for their clinical and cost-effectiveness and implementation has been established in urban settings, but there is a small amount of low-quality evidence for rural and regional settings. The Grampians Region Health Service Partnership Resi-In-Reach Redesign Committee will be implementing a new RIR program to be offered to all RACHs in the Grampians region, this project aims to evaluate the clinical and cost-effectiveness of this program, and its implementation in the rural and regional setting. A stepped-wedge trial will be conducted so that as the RIR program is gradually rolled-out across the region, outcomes can be compared in the same facilities across time and between different facilities. The primary outcome measure will be presentation to emergency departments and urgent care centres, and data will also be collected on other clinical outcomes and barriers and enablers of implementing the program. It is anticipated that there will be a reduction in hospital presentations, and a range of barriers and enablers unique to the rural and regional setting will emerge.

Conditions
Aged, Acute Disease
Being tested
Residential In-Reach Program
Keywords
stepped-wedge trial, residential aged care home, residential in reach, hospital avoidance
Medical subject headings
Acute Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Residential In-Reach ProgramOther

    All enrolled residential aged care homes will be able to access the residential-in-reach (RIR) program intervention. The RIR program provides a consultation service from a central hospital to an aged care facility in the Grampians region in the state of Victoria, Australia. Aged care staff will make a telehealth referral to central hub, where a nurse practitioner will triage the patient and make recommendations (for example, monitor resident condition, more examples: comprehensive assessment for unwell residents, liaison with the General Practitioners for diagnosis and treatment plan, provide education and support to staff) or further referrals (for example, refer to geriatrician or call an ambulance).

Study groups in NCT06901167
Study groupRoleWhat they receive
Residential-in-reachExperimentalAll enrolled residential aged care homes will be able to access the residential-in-reach (RIR) program intervention. The RIR program provides a consultation service from a central hospital to an aged care facility in the Grampians region in the state of Victoria, Australia. Aged care staff will make a telehealth referral to central hub, where a nurse practitioner will triage the patient and make recommendations (for example, monitor resident condition, more examples: comprehensive assessment for unwell residents, liaison with the General Practitioners for diagnosis and treatment plan, provide education and support to staff) or further referrals (for example, refer to geriatrician or call an ambulance).
Receives: Other: Residential In-Reach Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of presentations from residential aged care homes to emergency departments and emergency care centres

    Primary clinical effectiveness outcome

    Collection schedule:

    • Once at the end of the evaluation
    • At the level of each residential aged care home presentation to hospital each month Collection approach: Extraction from hospital records and extraction from residential aged care home systems

    Measured: From enrolment to the end of the trial for 14 months

Secondary outcomes (9)
  1. Days spent in hospital by aged care home resident

    Secondary clinical effectiveness outcome

    Collection schedule:

    • Once at the end of the evaluation
    • At the level of each residential aged care home presentation to hospital each month Collection approach: Extraction from hospital records and extraction from residential aged care home systems

    Measured: From enrolment to the end of the trial for 14 months

  2. Location of mortality in hospital

    Secondary clinical effectiveness outcome

    Collection schedule:

    • Once at the end of the evaluation
    • At the level of each residential aged care home presentation to hospital each month Collection approach: Extraction from hospital records and extraction from residential aged care home systems

    Measured: From enrolment to the end of the trial for 14 months

  3. Number of barriers to residential-in-reach program implementation

    Secondary implementation outcome - collected once via semi-structured interviews with key stakeholders (health service staff, residential aged care home staff).

    Measured: From enrolment to 1 month after the end of the trial, for 15 months

  4. Number of enablers to residential-in-reach program implementation

    Secondary implementation outcome - collected once via semi-structured interviews with key stakeholders (health service staff, residential aged care home staff).

    Measured: From enrolment to 1 month after the end of the trial, for 15 months

  5. Stakeholder reported feasibility of the residential-in-reach program implementation

    Secondary implementation outcome - collected once via semi-structured interviews with key stakeholders (health service staff, residential aged care home staff).

    Measured: From enrolment to 1 month after the end of the trial, for 15 months

  6. Stakeholder reported acceptability of the residential in-reach program

    Secondary implementation outcome - collected via semi-structured interviews with key stakeholders (health service staff, residential aged care home staff, general practitioners, aged care home residents) after occasions of service on a monthly basis.

    Measured: From enrolment to the end of the trial for 14 months

  7. Stakeholder reported appropriateness of the residential in-reach program

    Secondary implementation outcome - collected via semi-structured interviews with key stakeholders (health service staff, residential aged care home staff, general practitioners, aged care home residents) after occasions of service on a monthly basis.

    Measured: From enrolment to the end of the trial for 14 months

  8. Number of aged care staff who attend education sessions for the use of the residential in-reach program

    Secondary implementation outcome - recorded attendance of education sessions for residential aged care home staff for the use of the residential in-reach program.

    Measured: From enrolment to the end of the trial for 14 months

  9. Number of adaptations made to the residential in-reach program

    Secondary implementation outcome - documented adaptations made to the program during the trial period.

    Measured: From enrolment to the end of the trial fo

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start1 May 2025
  3. Primary completion31 May 2026 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
This will be a stepped-wedge trial, in which all enrolled facilities and participants will receive the same intervention, but the intervention roll-out will be conducted in a sequential manner based on a randomised order. During the 14 months of the trial, all facilities and participants will receive the same intervention, but for different lengths of time depending on the randomisation.
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06901167
Sponsor's protocol ID
HREC/112397/GHSJOG-2025-462490
Status last verified
Mar 2025
First submitted
4 Mar 2025
Last updated
30 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be analysed and reported on. Planned data management involves analysis and reporting of aggregated data from all participants from all sites.

Publications

  • Sunner C, Giles MT, Parker V, Dilworth S, Bantawa K, Kable A, Oldmeadow C, Foureur M. PACE-IT study protocol: a stepped wedge cluster randomised controlled trial evaluating the implementation of telehealth visual assessment in emergency care for people living in residential aged-care facilities. BMC Health Serv Res. 2020 Jul 20;20(1):672. doi: 10.1186/s12913-020-05539-1.

    PubMed 32690008
  • Sunner C, Giles MT, Kable A, Foureur M. Experiences of nurses working in RACFs and EDs utilising visual telehealth consultation to assess the need for RACF resident transfer to ED: A qualitative descriptive study. J Clin Nurs. 2023 Aug;32(15-16):4694-4709. doi: 10.1111/jocn.16529. Epub 2022 Sep 8.

    PubMed 36081333
  • Lukin B, Fan LJ, Zhao JZ, Sun JD, Dingle K, Purtill R, Tapp S, Hou XY. Emergency department use among patients from residential aged care facilities under a Hospital in the Nursing Home scheme in public hospitals in Queensland Australia. World J Emerg Med. 2016;7(3):183-90. doi: 10.5847/wjem.j.1920-8642.2016.03.004.

    PubMed 27547277
  • Hullick C, Conway J, Hall A, Murdoch W, Cole J, Hewitt J, Oldmeadow C, Attia J. Video-telehealth to support clinical assessment and management of acutely unwell older people in Residential Aged Care: a pre-post intervention study. BMC Geriatr. 2022 Jan 10;22(1):40. doi: 10.1186/s12877-021-02703-y.

    PubMed 35012480
  • Haines TP, Palmer AJ, Tierney P, Si L, Robinson AL. A new model of care and in-house general practitioners for residential aged care facilities: a stepped wedge, cluster randomised trial. Med J Aust. 2020 May;212(9):409-415. doi: 10.5694/mja2.50565. Epub 2020 Apr 1.

    PubMed 32237279
  • Chambers D, Cantrell A, Preston L, Marincowitz C, Wright L, Conroy S, Lee Gordon A. Reducing unplanned hospital admissions from care homes: a systematic review. Health Soc Care Deliv Res. 2023 Oct;11(18):1-130. doi: 10.3310/KLPW6338.

    PubMed 37916580

Questions about this trial

What is this clinical trial studying?

A study testing Residential In-Reach Program in people with Aged and Acute Disease, run by Monash University at 8 sites in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dai Pu (61 03 9904 4004, debbie.pu@monash.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of presentations from residential aged care homes to emergency departments and emergency care centres (time frame: From enrolment to the end of the trial for 14 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06901167, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in